Sun Pharma Advanced Research trades higher on the BSE

14 Mar 2019 Evaluate

Sun Pharma Advanced Research Company is currently trading at Rs. 199.50, up by 6.15 points or 3.18% from its previous closing of Rs. 193.35 on the BSE.

The scrip opened at Rs. 192.00 and has touched a high and low of Rs. 200.60 and Rs. 192.00 respectively. So far 104248 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 438.25 on 24-Apr-2018 and a 52 week low of Rs. 140.95 on 06-Feb-2019.

Last one week high and low of the scrip stood at Rs. 203.50 and Rs. 188.00 respectively. The current market cap of the company is Rs. 5235.71 crore.

The promoters holding in the company stood at 68.11%, while Institutions and Non-Institutions held 7.77% and 24.12% respectively.

Sun Pharma Advanced Research Company (SPARC) and HitGen have collaborated to identify novel small molecule leads for targets of interest. Under this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for SPARC.

Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

134.45 0.70 (0.52%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 643.75
Indegene 519.25
CMS Info Systems 339.55
Sagility 52.19
Smartworks Coworking 476.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×